SciStem, Inc
SciStem, Inc is a platform technology company developing second-generation stem cell-based regenerative therapies for bone healing and osteoarthritis in pets.
- Stage Product In Development
- Industry Biotechnology
- Location Athens, Georgia, US
- Currency USD
- Founded September 2012
- Website SciStem.com
Company Summary
SciStem is the only animal healthcare company solely focused on developing a pipeline of FDA-regulated “off-the-shelf"(universal donor) stem cell therapies for pets. The Company’s lead program is indicated for rapid bone regeneration at the osteotomy site in dogs undergoing cranial cruciate ligament repair, and for complex fractures and non unions. Secondary programs are in development for the treatment of osteoarthritis in dogs and horses.
Team
-
Co-Founder & Chief Executive OfficerDr. Black is the former VP Product Development at Vet-Stem, the first veterinary regenerative medicine company. She led the clinical development strategy and product team to develop allogeneic FDA-regulated cell therapy products in dogs.
Dr. Black received a DVM from the University of Wisconsin-Madison and a PhD in Cell and Molecular Biology from the University of Pennsylvania, School of Medicine. -
Vice President of Operations & FinanceMs. Treadwell brings over 10 years of experience in accounting and financial management with a focus on stem cell therapy applications. She has worked closely on compliance with international licensing agreements and maintained financial records for government contracts. Her expertise includes a unique approach to operational procedures, streamlining, and cash flow management.
Advisors
-
Director
Patrick WestAdvisorUnconfirmed
Robert Guldberg, PhDAdvisorUnconfirmed -
Steve Stice, PhDCo-Founder, Director & Chair Scientific Advisory BoardUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.